NAUT:NASDAQ, Nautilus Biotechnology, Inc.

NAUT stock overview

Nautilus Biotechnology, Inc. (NAUT:NASDAQ) closed at $2.32 on November 13, 2026, down 2.52% on the day. The stock trades 46.2% below its 52-week high of $4.31 and 175.9% above its 52-week low of $0.841. Over the past year, it gained 22.1%. Nautilus Biotechnology, Inc. is part of the Health Care sector.

Key figures

Price: $2.32
Day change: -2.52%
Volume: 1,874,443
Average volume: 5,929,679
Market cap: 295M+
52-week range: $0.841 – $4.31
50-day average: $1.84
200-day average: $2.13

Price action over the past year

In 252 trading sessions since November 13, 2025, NAUT closed higher on 114 days (45%). Its best day was October 19, 2026 (+27.67%) and its worst was July 28, 2026 (-27.71%). The stock moved 10% or more in a single session 35 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

Nov 14, 2026: Trading sideways between $2.15 and $2.42 over 14 days (Sideways scanner)
Oct 29, 2026: Spiked to $3.42 on 7M+ shares (Spikes scanner)
Oct 27, 2026: News catalyst: Earnings (News Catalysts scanner)

NAUT news

Nov 5, 2026: Nautilus: 3 Key Takeaways for Long-Term Investors
Oct 27, 2026: Nautilus Biotechnology, Inc. Q3 2026 Earnings Call Summary
Oct 27, 2026: Nautilus (NAUT) Q3 2026 Earnings Call Transcript
Oct 27, 2026: Nautilus Beats On A Narrower-Than-Expected Loss, But Rising Spending And A Looming Raise Shadow Strong Proteoform Data
Oct 27, 2026: Nautilus Biotechnology Q3 Earnings Call Highlights
Oct 27, 2026: Nautilus to Measure Proteoforms Driving Alzheimer's Disease and Cancer in ARPA-H-Funded SEEDS Consortium
Oct 27, 2026: Nautilus Biotechnology Reports Third Quarter 2026 Financial Results
Oct 15, 2026: Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026

About Nautilus Biotechnology, Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.

Similar stocks

Find more stocks like NAUT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.